DIALYSIS · CCN 672860

USRC Premier

HOUSTON, TX 77054

DialysisProfitUS Renal Care, Inc.
$3.5M
TOTAL REVENUE
-2.1%
OPERATING MARGIN
2 / 5
STAR RATING
14
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.5M
Total costs
$3.6M
Operating income (rev − costs)
−$72K
Operating margin
-2.1%
Total charges
$3.5M
Total treatments
8,949
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

14 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9169—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8125—
Fistula Rate
DFC_FISTULA_RATE
57.173—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
031—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
121.346—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
072—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.18——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2573—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.3221—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
14.874—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
35.143—
Standardized ED Visits Ratio
DFC_SEDR
1.0414—